Headline
The latest stories from AHA Today.
The Food and Drug Administration June 22 approved the first gene therapy to treat patients aged 4-5 with a confirmed mutation in the Duchenne muscular dystrophy gene.
Medicare will cover new Alzheimer’s drugs that receive traditional approval from the Food and Drug Administration when a beneficiary is diagnosed with mild cognitive impairment or Alzheimer’s disease dementia and has a physician participating in a registry with an appropriate clinical team and…
The Centers for Medicare and Medicare Services will host a June 27 webinar on its Review Choice Demonstration for Inpatient Rehabilitation Services, which will begin Aug. 21 in Alabama and expand to additional states at an undetermined date.
Delivery-related maternal mortality in U.S. hospitals decreased for all racial and ethnic groups, age groups and modes of delivery during 2008 to 2021, likely due to national strategies to improve delivery-related hospital care, the Department of Health and Human Services reported.
A bipartisan group of 233 representatives and 61 senators called on the Centers for Medicare & Medicaid Service to enhance its proposal to streamline prior authorization processes in Medicare Advantage, Medicaid and the federally-facilitated Marketplace to require real-time electronic decision-…
In a letter submitted to the House Energy and Commerce Subcommittee on Oversight and Investigations for a hearing on challenges implementing value-based and alternative payment models under the Medicare Access and CHIP Reauthorization Act of 2015, AHA encouraged certain statutory and regulatory…
A bipartisan group of 87 representatives urged the Centers for Medicare & Medicaid Services to reevaluate its proposed payment update for the inpatient prospective payment system for fiscal year 2024, expressing concern that the proposed update does not accurately reflect the current costs of…
Waleed Javaid, M.D., director of infection prevention and control at Mount Sinai Health System in New York, shares successful strategies for eliminating healthcare-associated infections.
The Substance Abuse and Mental Health Services Administration today issued an advisory offering evidence-based resources to help clinicians assess and treat mental health symptoms and conditions associated with Long COVID, from fatigue and sleep disturbances to depression, anxiety and post-…
In a statement submitted to the House Education and Workforce Subcommittee on Health, Employment, Labor, and Pensions for a hearing today on competition and transparency in health care, AHA said mergers and acquisitions are important tools that some hospitals use to lower costs and…